Lumen’s AI Analysis Frees Production Optimization from DOE Limits

by admin | Dec 7, 2022 | Press Release

Read more

Improving combination drug trials using ‘definitive screening designs’

by admin | Nov 18, 2022 | Publications

Read more

On the Horizon, Needle-Free Vaccines could Offer Better Protection and Access

by admin | Oct 25, 2022 | Press Release

Read more

Needle-free, spirulina-produced Plasmodium falciparum circumsporozoite vaccination provides sterile protection against pre-erythrocytic malaria in mice

by admin | Oct 4, 2022 | Publications

Read more

Lumen Bioscience Announces Publication in NPJ Vaccines of Preclinical Data Demonstrating Needle Free, Spirulina-produced Vaccination Offering Protection Against Malaria

by admin | Oct 4, 2022 | Press Release

Lumen Bioscience, a clinical-stage biotechnology company developing biologic drugs for highly prevalent diseases, today announced the publication of data demonstrating a needle-free, spirulina-produced recombinant vaccine that protects against malaria. The research,...